AI and semiconductor stocks are gaining significantly ahead of the open on Wall Street, extending a strong rally following a recent broad-market sell-off after U.S. President Donald Trump secured $600 billion in commitments from Saudi Arabia for U.S. tech companies during a tour of the Gulf states. Nvidia (NVDA.US) has agreed to sell hundreds of thousands of AI chips in Saudi Arabia as part of a U.S.-Saudi partnership, a sign that demand for the chips is still growing. The corporation, along with Advanced Micro Devices (AMD.US) and Qualcomm (QCOM.US), announced deals with Humain, an AI startup launched Monday by a Saudi sovereign wealth fund.
Meanwhile, shares of Super Micro Computer (SMCI.US) are up 18% premarket.
NVDA and AMD stocks trade higher in Europe ahead of the open on Wall Street.
Source: xStation
Daily Summary: U.S. stock indices are climbing following the PPI data
AI needs power and thatโs where the profits are. Oracle and Bloom set the path.
US OPEN: Wall Street Rallies on Soft PPI Data
Novo Nordisk announces a strategic partnership with OpenAI๐งฌ๐ค
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
